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Abstract
Infiltration of Ly6Chi monocytes from the blood is a hallmark of viral encephalitis. In mice with lethal encephalitis
caused by West Nile virus (WNV), an emerging neurotropic flavivirus, inhibition of Ly6Chi monocyte trafficking into
the brain by anti-very late antigen (VLA)-4 integrin antibody blockade at the time of first weight loss and leukocyte
influx resulted in long-term survival of up to 60% of infected mice, with subsequent sterilizing immunity. This
treatment had no effect on viral titers but appeared to be due to inhibition of Ly6Chi macrophage immigration.
Although macrophages isolated from the infected brain induced WNV-specific CD4+ T-cell proliferation, T cells did
not directly contribute to pathology, but are likely to be important in viral control, as antibody-mediated T-cell
depletion could not reproduce the therapeutic benefit of anti-VLA-4. Instead, 70% of infiltrating inflammatory
monocyte-derived macrophages were found to be making nitric oxide (NO). Furthermore,
aminoguanidine-mediated inhibition of induced NO synthase activity in infiltrating macrophages significantly
prolonged survival, indicating involvement of NO in the immunopathology. These data show for the first time the
therapeutic effects of temporally targeting pathogenic NO-producing macrophages during neurotropic viral
encephalitis.
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Findings
During autoimmune or infectious inflammation of the
central nervous system (CNS), inflammatory monocytes
migrate into the brain, where they can differentiate into
microglia, macrophages, and even dendritic cells [1-3].
The major function of infiltrating inflammatory mono-
cytes is to initiate and amplify the immune response
[4-6], but we have recently shown that immigration of
these cells into the brain infected with West Nile virus
(WNV) contributes directly to the immune pathology
of the disease [2]. Inhibition of migration of these cells
by anti-chemokine (C-C motif ) ligand 2 (CCL2) anti-
body resulted in a short prolongation of survival in
WNV-infected animals [2]. In this report, we extend
these findings to show that inflammatory monocyte-
derived macrophages not only migrate into the WNV-
infected CNS, utilizing very late antigen (VLA)-4, but
play a significant role in driving the immune-mediated
pathology, at least in part through sustained production
of NO in the symptomatic stages of disease. Importantly,
for potential clinical translation, we show that pulsed
anti-VLA-4 therapy during acute disease increases the
survival of infected animals.
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Figure 1 (See legend on next page.)




All procedures were conducted with approval from the
animal ethics committee of Sydney University.
Animals
Female C57BL/6 mice were intranasally inoculated with
6 × 104 or 6 × 103 plaque-forming units (PFU) WNV
(Sarafend; Generated as described in 2) or phosphate
buffered saline (PBS; Sham control) under anesthesia at
8 weeks old, as previously described [2,7]. For in vivo
antibody treatments, mice were injected daily with 100 μg
anti-CD49d (VLA-4), CD11a (lymphocyte function-
associated antigen-1; LFA-1), CD4, CD8 or isotype
control antibodies (Biolegend, San Diego, CA, USA intra-
peritoneally from day 6 post-infection (p.i.) titrated for
maximal effect. For in vivo NO inhibition, mice were
injected with 300 mg/kg aminoguanidine hemisulfate
(Sigma) intraperitoneally from day 6 p.i.. For in vivo
cathespin labeling, mice were intravenously injected with
2 nmol/l of a fluorescent agent (ProSense; VisEn Medical,
Bedford, MA, USA) on day 6 p.i.. Mice were killed on
day 7 p.i. by cardiac perfusion under anesthesia, as
previously described [7]. To determine virus titers,
plaque assays using homogenized brain on baby hamster
kidney cell monolayers were conducted as previously
described [7]. For immunohistology, brains were cut into
8 μm sections and stained with anti-CD54 (intercellular
adhesion molecule-1; ICAM-1), CD106 (vascular cell ad-
hesion molecule 1; VCAM-1), isotype control antibodies
(Biolegend), or anti-iNOS (Neomarkers Inc., Fremont,
CA, USA), using a previously described immunohisto-
chemical protocol [2]. In situ hybridization for NOS2 was
conducted as previously described [7], using a P33-labeled
cRNA probe. For flow-cytometry analysis, leukocytes iso-
lated from the brain and blood were incubated with
CD16/32 antibody and then labeled with fluorochrome-
conjugated CD45, CD11b, Ly6C, Ly6G, F4/80, CD3,
CD4, CD8, major histocompatibility complex (MHC)-II,
CD80, CD86, CD49d (VLA-4), CD11a (LFA-1) or iso-
type control antibodies (Biolegend), using a previously
described flow-cytometry protocol [2]. For detection of
intracellular NO, cells were incubated with 5 μmol/l of
a green fluorescent marker that is activated by NO
(4-amino-5-methylamino-2',7'-difluorofluorescein diacetate
(DAF-FM); Invitrogen Corp., Carlsbad, CA, USA) for 30
minutes as previously described [8]. Fluorescence was mea-
sured, and cell sorting carried out (FACS ARIA; Becton
Dickinson, Franklin Lakes, NJ, USA) and analyzed using
flow-cytometry software (FlowJo; TreeStar Inc., Ashland,
OR, USA). For T-cell proliferation assays, Ly6Chi macro-
phages, Ly6C− microglia and CD4+ Tcells were sorted from
the brains of colony-stimulating factor 1 receptor (cFMS)-
enhanced green fluorescent protein (EGFP) chimeras
(described previously [2]) and spleens of C57BL/6 mice on
day 7 p.i.. cFMS-EGFP is the promoter for CD115 (the
macrophage colony-stimulating factor receptor), thus, in
these mice, macrophages express EGFP. Assays using
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assays were conducted in accordance with the
manufacturer’s instructions (Invitrogen Corp.), with cells
plated at the indicated ratios and incubated for a total of 72
hours.
Statistical analysis
Statistical analysis was conducted using one-way
ANOVA with a Tukey-Kramer post hoc test, and statis-
tical analysis of survival was conducted using the
log-rank (Mantel-Cox) test. Data shown are means ±
standard deviations. P < 0.05 was considered significant.
Results and discussion
Expression of integrins and cellular adhesion molecules
Previously, we have shown that WNV infection triggers
significant limbic-seizure responses that occur immedi-
ately preceding death [7]. In addition, acute weight loss
correlates with the infiltration of T cells (14%) and
(See figure on previous page.)
Figure 1 VLA-4 is the primary integrin for inflammatory monocyte derived macrophages. Analysis at day 7 p.i. showed (A) CD4+ and CD8+
T cells, Ly6G+ neutrophils (~6%, 7% and 3%, respectively, of all infiltrating leukocytes), and large numbers of Ly6C+ macrophages (~50% of
infiltrating leukocytes, of which >90% were Ly6Chi) infiltrating into the brain from day 5 p.i., and (B) lymphocyte function-associated antigen
(LFA)-1 and very late antigen (VLA)-4 was expressed on Ly6Clo and Ly6Chi blood monocytes. (C) Immunohistochemical staining for intercellular
adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 performed on day 7 p.i. on the sham-infected and WNV-infected
brains of C57BL/6 mice showed significant widespread upregulation of both molecules in WNV-infected mice and co-localized with CD31.
Treatment with 100 μg anti-VLA-4 antibody from day 6 p.i. onwards resulted in reduced neutrophil and T cell recruitment into day 7 p.i.
WNV-infected brains. A 66% reduction was seen in the CD45+/CD11b+/Ly6G−/Ly6Chi macrophage compartment. (D) By contrast, LFA-1 blockade
reduced Ly6Chi macrophage infiltration by 33%. (E) VLA-4 blockade resulted in increased survival of 10 to 60%, depending on the inoculation
dose (P < 0.001), whereas (F) LFA-1 blockade did not increase survival. (G) Viral titers in the brain at day 7 p.i. were similar in all treatment groups.
Data are representative of at least three independent experiments with at least four mice per group. Antibody-mediated effects on the disease
course were determined on four separate occasions with at least ten mice per group. Data shown are the mean ± standard deviation. Statistical
analysis was conducted using one-way ANOVA with a Tukey-Kramer post hoc test. Statistical analysis of survival was conducted using the log-rank
(Mantel-Cox) test. * P < 0.05; **P < 0.001; ***P < 0.001. The inoculation dose used was 6 × 103 plaque-forming units, unless otherwise noted.
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neutrophils (3%), but the most striking infiltration (by
both number and percentage) are Ly6C-expressing in-
flammatory macrophages (~50%) (Figure 1A). This infil-
tration occurs between days 5 and 7 p.i. (Figure 1A) and
without detectable blood–brain barrier disruption in
most mice [2]. We could not isolate any from sham-
infected mice (Figure 1A) [2]. The mechanism by which
inflammatory monocytes enter the brain during WNV
Figure 2 (See legend on next page.)
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infection has not been addressed. LFA-1 and VLA-4 are
integrins important for trans-endothelial migration [9],
and were expressed on blood monocytes in WNV-
infected and sham-infected mice (Figure 1B). Although
a trend toward increased VLA-4 expression on mono-
cytes from WNV-infected mice was seen, it was not
significant. Furthermore, expression of the respective
ligands for these integrins, ICAM-1 and VCAM-1, was
upregulated in the WNV-infected brain. Expression of
both ligands was found on platelet endothelial cell adhe-
sion molecule-positive cerebrovascular endothelium
(Figure 1C). To investigate the functional role of these
integrins, we injected VLA-4-blocking antibody intraperi-
toneally into WNV-infected mice on day 6 p.i.. Although
T-cell numbers decreased, the most dramatic reduction
was seen in inflammatory monocyte-derived Ly6Chi
macrophages. This reduction was significantly greater in
mice treated with anti-VLA-4 than in those treated with
anti-LFA-1 (Figure 1D). VLA-4 antibody blockade
resulted in reduced encephalitic symptoms, including a
reduction in the incidence of seizures (not shown),
culminating in enhanced long-term survival of 10 to
60% of mice (P < 0.001), with subsequent immunity to
virus rechallenge, depending on the inoculating dose
of virus used (Figure 1E). By contrast, LFA-1 blockade
had no effect on the disease course (Figure 1F).
Neutralization of LFA-1 or VLA-4 had no effect on
viral titers in the brain on day 7 p.i. (Figure 1G), suggest-
ing that survival is not the result of reductions in viral bur-
den or virus cytotoxicity. However, the data support our
previous findings suggesting that increased survival is the
direct result of decreased inflammatory monocyte traffick-
ing into the brain [2].
The mechanism by which these cells contribute to the
pathogenesis of disease is unresolved. To address this,
we initially investigated the ability of these cells to
process and present antigen to T cells, as CNS macro-
phages exhibited cathepsin activity and expressed MHC-
II and CD86 (Figure 2A-C), and we hypothesized that
infiltrating macrophages might exert their pathogenic
effects indirectly acting as antigen presenting cells (APC),
via T-cell stimulation. Using naive and activated CD4+ T
cells, we tested from day 7 p.i. the capacity of immigrant
brain macrophages and resident microglia to stimulate T-
cell proliferation (Figure 2D). Whereas the control Ly6C–
(resident) microglia failed to stimulate T-cell proliferation,
inflammatory monocyte-derived macrophages were capable
of inducing proliferation of activated T cells, supporting
previous studies showing that macrophages can stimulate
anti-WNV T-cell responses [10]. It is tempting to speculate
from these data that inflammatory monocyte-derived
macrophages may cause immunopathology via their influ-
ence on T cells [11]; however, deletion of either CD4+ or
CD8+ T cells, or both, did not increase survival time in
these mice (Figure 2E). When considered with the reduced
number of T cells seen after anti-VLA-4 treatment, these
data potentially argue against a role for T cells in causing
the observed immune pathology in WNV-infected mice.
Indeed, previous studies have shown that in concert with
neuronal intracellular antiviral defenses, T cells are import-
ant for viral clearance [12-14]. Examination of these path-
ways in VLA-4 treated mice will be needed to clarify these
viral eradication mechanisms precisely.
Because NO production during viral infection has
been shown to be protective in some instances, and
pathogenic in others, we investigated the possible patho-
genic role of NO production by macrophages [15-18].
In situ hybridization and immunohistochemistry for
inducible NO synthase (NOS)-2 showed significant
expression in the WNV-infected brain at day 7 p.i.
(Figure 3A-F). Flow cytometry using the NO marker
DAF-FM diacetate [8], which becomes fluorescent when
it reacts with NO, showed that 72% of macrophages
in the WNV-infected brain expressed NO, compared
with only 24% of resident microglia (CD45Lo/Ly6C−)
(Figure 3G). Furthermore, intraperitoneal administration
of aminoguanidine from day 6 p.i. resulted in an increased
survival of up to 4 days for infected mice (Figure 3H), with
the percentage of DAF-FM+macrophages decreasing to
less than 12% (Figure 3G). Furthermore, increased survival
(See figure on previous page.)
Figure 2 Assessment of macrophages isolated from the West Nile virus (WNV) infected brain. (A, B) Macrophages isolated from day 7 p.i.
brain tissue infected with West Nile virus expressed major histocompatability complex (MHC)-II and CD86. (C) More than 70% of Ly6Chi
macrophages in the WNV-infected brain were positive for fluorescent agent (ProSense; VisEn Medical, Bedford, MA, USA), indicative of cathepsin
activity. (D) The ability of macrophages (CD45+/CD11b+/Ly6G−/GFP+/CD11c−/Ly6Chi) and resident microglia (CD45lo/int/CD11b+/GFP−/
CD11c−/Ly6Chi), isolated from WNV-infected colony-stimulating factor 1 receptor (cFMS)-enhanced green fluorescent protein (EGFP) chimeric
mice [2] to stimulate naïve and activated CD3+/CD4+ T cells from sham-infected and WNV-infected mice, respectively, was measured. Except at
the highest antigen-presenting cell (APC):CD4 ratios, neither population was capable of stimulating naive T-cell proliferation, as measured by
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. (E) Notwithstanding the apparent APC capabilities, depletion of CD8+ or
CD4+ or CD4+ and CD8+ had no effect on overall survival in this model. All experiments were performed at least twice with four to five mice per
group. Cells were sorted from 10 pooled cFMS-EGFP chimeric mice, and data represent the mean of triplicate wells and the standard deviation of
absorbance. T-cell depletion was performed at least twice with eight to ten mice per group. Statistical analysis was conducted using one-way ANOVA
with a Tukey-Kramer post hoc test. * Indicates significance of comparison of CD4+ T-cell proliferation between wells with macrophages and wells with
CD4+ T cells only. * P < 0.05; **P < 0.001; ***P < 0.001. Mice infected with 6 ×104 plaque-forming units were used to obtain APC populations.
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in VLA-4- treated mice correlated with a significant re-
duction in NO+ macrophages in the brain (Figure 3I) at
day 7 p.i. Taken together, these data show that inhibition
of Ly6Chi monocyte-derived NO, either by reducing the
immigration of these cells into the brain, or by inhibiting
NO, promotes survival in WNV encephalitis.
Although the production of other pro-inflammatory
mediators is also likely to occur via inflammatory
Figure 3 (See legend on next page.)
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monocyte-derived macrophages, these data provide one
potential lethal effector function for pathogenic macro-
phages that infiltrate into the WNV-infected brain. The
production of NO by macrophages is integral to clear-
ance of many invading pathogens and mediates viral
clearance in models of HSV-2, Ectromelia and Vaccinia
virus infection [16]. Over-exuberant NO production can
be pathogenic, as exemplified by infection by another
flavivirus, Murray Valley encephalitis virus, in which
experimental inhibition of NO attenuated disease and
prolonged survival [15]. During WNV encephalitis,
more than 70% of the inflammatory monocyte-derived
macrophages in the WNV-infected brain produced
NO. Importantly, whereas inhibition of NO with ami-
noguanidine over the entire course of infection had no
effect on disease outcome, inhibiting NO on day 6 p.i.
resulted in enhanced survival of WNV-infected mice.
This apparently paradoxical effect suggests that NO may
be important in the early control of WNV infection,
whereas later, the sustained production of NO by large
numbers of infiltrating macrophages becomes poorly
regulated and thus pathogenic. This is supported by previ-
ous macrophage-depletion studies, which show that early
prolonged macrophage depletion can result in brain infec-
tion in mice infected with a non-encephalogenic WNV
strain [19]. It is important to consider that although NOS-2
in situ hybridization studies support a role for macrophages
in NO production during WNV encephalitis, NO may also
be produced by neurons (neuronal NOS; NOS-1) and
endothelium (endothelial NOS; NOS-3). Because arginine
is required as a substrate for the production of NO by all
forms of NOS, and aminoguanidine competes with arginine
at all these sites, we cannot determine with certainty that
the effect we found after aminoguanidine administration is
due to the inhibition of NO within macrophages, endothe-
lium, or neurons. In addition, in the brain, NO modulates
neurotransmission. Because WNV infection of the brain
causes severe seizures, and other studies have implicated
NO in the modulation of neuronal function [7], the
ability of NO inhibition at day 6 p.i. to enhance survival of
infected mice may also be the result of aminoguanidine
interactions that stabilize neurons within the WNV-
infected brain. The lack of seizures seen in interferon- γ
(IFN-γ−/−) mice, as previously described [7], supports this
hypothesis. This is because mice deficient in IFN-γ have
reduced ability to produce NO and do not develop seizures
[7]. However, in IFN-γ−/− mice, only the NO produced via
NOS-2 is reduced. Similar survival kinetics were reported
with WNV-infected IFN-γ−/− mice [7] compared with wild-
type mice receiving aminoguanidine from day −1 p.i.
throughout the disease course. Together this strongly sug-
gests that the antiviral effects of NOS-2-induced NO are
important early during infection and contrasts with its evi-
dent pathogenic function, probably via similar mechanisms,
late in the disease.
In conclusion, we show here that macrophages derived
from Ly6Chi inflammatory monocytes predominantly
utilize VLA-4 to enter the CNS. Abrogation of this migra-
tion by integrin blockade resulted in long-term survival
and immunity in an otherwise lethal model. Finally, these
data show the crucial contribution by inflammatory
macrophages, within in a narrow, temporally defined win-
dow, to the immunopathogenesis of disease. This should
inform interventional approaches that can ameliorate
immunopathology by targeting a specific myeloid subset
(s) in the short term, while enabling virus clearance and
host survival.
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Figure 3 Macrophages produce NO, which is pathogenic during WNV infection. (A-E) Analysis of sections from sham-infected and West
Nile virus (WNV)-infected mice at day 7 p.i. showed significant upregulation of nitric oxide synthase (NOS)-2 message in the WNV-infected brains.
(C, F) Furthermore, immunohistochemical staining for NOS-2 protein (red) and lectin (green) showed that most cells expressing NOS-2 in the
WNV-infected brain parenchyma at day 7 p.i. were lectin-positive. (G) Using the dye 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate
(DAF-FM), which, in the presence of NO becomes fluorescent, flow cytometry showed that more than 70% of macrophages (CD45hi/CD11b
+/CD11c−/Ly6C+) expressed NO compared with approximately 25% of resident microglia (CD45lo/int/CD11b+/CD11c−/Ly6C−), and treatment of
mice with aminoguanidine resulted in a significant reduction in macrophages expressing NO. (H) Inhibition of NO with aminoguanidine did not
increase survival when used over the entire infectious period, but it had a demonstrably protective effect given at day 6 p.i. (P < 0.05). (I) A
significant reduction in DAF-FM-positive macrophages was seen from day 7 p.i. in the brains of WNV-infected mice that had been treated with
anti-VLA-4 neutralizing antibodies on day 6 p.i. In situ hybridization was performed on sagittal brain sections from at least six mice per group.
DAF-FM data are representative of three experiments with at least three mice per group. Aminoguanidine therapy was performed four times with
at least ten mice per group. Values shown are means ± SD. Statistical analysis was conducted using one-way ANOVA with Tukey-Kramer post hoc
test. * P < 0.05; **P < 0.001; ***P < 0.001. Statistical analysis of survival was determined using the log-rank (Mantel-Cox) test. *P < 0.05 was
considered significant.
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